1. Home
  2. CODX vs AIMD Comparison

CODX vs AIMD Comparison

Compare CODX & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CODX
  • AIMD
  • Stock Information
  • Founded
  • CODX 2013
  • AIMD 1984
  • Country
  • CODX United States
  • AIMD United States
  • Employees
  • CODX N/A
  • AIMD N/A
  • Industry
  • CODX Medical/Dental Instruments
  • AIMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • CODX Health Care
  • AIMD Health Care
  • Exchange
  • CODX Nasdaq
  • AIMD Nasdaq
  • Market Cap
  • CODX 9.8M
  • AIMD 8.2M
  • IPO Year
  • CODX 2017
  • AIMD N/A
  • Fundamental
  • Price
  • CODX $0.28
  • AIMD $0.51
  • Analyst Decision
  • CODX Buy
  • AIMD
  • Analyst Count
  • CODX 2
  • AIMD 0
  • Target Price
  • CODX $5.50
  • AIMD N/A
  • AVG Volume (30 Days)
  • CODX 462.7K
  • AIMD 259.6K
  • Earning Date
  • CODX 08-07-2025
  • AIMD 08-04-2025
  • Dividend Yield
  • CODX N/A
  • AIMD N/A
  • EPS Growth
  • CODX N/A
  • AIMD N/A
  • EPS
  • CODX N/A
  • AIMD N/A
  • Revenue
  • CODX $3,497,583.00
  • AIMD $106,207.00
  • Revenue This Year
  • CODX N/A
  • AIMD N/A
  • Revenue Next Year
  • CODX $42.11
  • AIMD N/A
  • P/E Ratio
  • CODX N/A
  • AIMD N/A
  • Revenue Growth
  • CODX N/A
  • AIMD 13.38
  • 52 Week Low
  • CODX $0.23
  • AIMD $0.40
  • 52 Week High
  • CODX $2.23
  • AIMD $1.07
  • Technical
  • Relative Strength Index (RSI)
  • CODX 43.19
  • AIMD 38.36
  • Support Level
  • CODX $0.26
  • AIMD $0.49
  • Resistance Level
  • CODX $0.29
  • AIMD $0.52
  • Average True Range (ATR)
  • CODX 0.02
  • AIMD 0.05
  • MACD
  • CODX 0.00
  • AIMD -0.01
  • Stochastic Oscillator
  • CODX 26.83
  • AIMD 12.55

About CODX Co-Diagnostics Inc.

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Share on Social Networks: